|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diplegia, Spastic | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Cerebral Palsy | |||||
| Muscle Spasticity | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Damage, Chronic | |||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Muscle Hypertonia | |||||
| Muscular Diseases | |||||
| Musculoskeletal Diseases | |||||
| Nervous System Diseases | |||||
| Neurologic Manifestations | |||||
| Neuromuscular Manifestations | |||||
| Signs and Symptoms | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Neurological Disorders and Stroke (NINDS) | |||||